v3.25.1
Recapitalization - Schedule of Listing expense (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Fair value of TNL Mediagene equity consideration issued:        
Equity consideration issued (in Shares) 26,130,000 24,201,000 9,212,000 9,212,000
Listing expense amount $ 29,912,241      
Net assets of Blue Ocean as of December 5, 2024        
Listing expense (8,248,505)      
Excess of fair value of TNL Mediagene consideration issued over Blue Ocean net assets acquired 38,160,746      
Cash and Cash Equivalents [member]        
Net assets of Blue Ocean as of December 5, 2024        
Listing expense 2,653      
Financial Assets at Fair Value through Profit or Loss [member]        
Net assets of Blue Ocean as of December 5, 2024        
Listing expense 741,839      
Other payables [Member]        
Net assets of Blue Ocean as of December 5, 2024        
Listing expense (5,396,683)      
Promissory notes [Member]        
Net assets of Blue Ocean as of December 5, 2024        
Listing expense (2,562,102)      
Financial Assets at Fair Value through Profit or Loss [member]        
Net assets of Blue Ocean as of December 5, 2024        
Listing expense (610,028)      
Other Liabilities [member]        
Net assets of Blue Ocean as of December 5, 2024        
Listing expense $ (424,184)      
Public shareholders [Member]        
Fair value of TNL Mediagene equity consideration issued:        
Equity consideration issued (in Shares) 63,903      
Listing expense amount $ 685,040      
Sponsor shareholders [Member]        
Fair value of TNL Mediagene equity consideration issued:        
Equity consideration issued (in Shares) 2,726,418      
Listing expense amount $ 29,227,201